Načítá se...

Imaging of carbonic anhydrase IX with an (111)In-labeled dual-motif inhibitor

We developed a new scaffold for radionuclide-based imaging and therapy of clear cell renal cell carcinoma (ccRCC) targeting carbonic anhydrase IX (CAIX). Compound XYIMSR-01, a DOTA-conjugated, bivalent, low-molecular-weight ligand, has two moieties that target two separate sites on CAIX, imparting h...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Yang, Xing, Minn, Il, Rowe, Steven P., Banerjee, Sangeeta Ray, Gorin, Michael A., Brummet, Mary, Lee, Hye Soo, Koo, Soo Min, Sysa-Shah, Polina, Mease, Ronnie C., Nimmagadda, Sridhar, Allaf, Mohamad E., Pomper, Martin G.
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741798/
https://ncbi.nlm.nih.gov/pubmed/26418876
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!